Metraipolis › archive › dc_4dca48befdf9

Anakinra for tocilizumab-refractory febrile infection-related epilepsy syndrome with normal IL-1β levels: a case report — Europe PMC PMID:42367793

Source: Europe PMC (en)
Original: https://europepmc.org/article/MED/42367793
DOI: 10.3389/fimmu.2026.1866775
License (as archived): solo-consultazione
Archived: 2026-10-31T12:36:32.848Z
SHA-256 of the archived text: a1fe42f5ed67b9248d05085f1ea2dc93d1bf2f3809ca67cf2225dad3053b83bc
Stable URL of this page: https://metraipolis.com/documento/dc_4dca48befdf9

How to cite

Anakinra for tocilizumab-refractory febrile infection-related epilepsy syndrome with normal IL-1β levels: a case report — Europe PMC PMID:42367793 — Europe PMC (en), https://europepmc.org/article/MED/42367793 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_4dca48befdf9 (Metraipolis archive dc_4dca48befdf9, sha256 a1fe42f5ed67b9248d05085f1ea2dc93d1bf2f3809ca67cf2225dad3053b83bc)

BibTeX

@misc{dc4dca48befdf9,
  title = {Anakinra for tocilizumab-refractory febrile infection-related epilepsy syndrome with normal IL-1β levels: a case report — Europe PMC PMID:42367793},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42367793},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_4dca48befdf9; sha256 a1fe42f5ed67b9248d05085f1ea2dc93d1bf2f3809ca67cf2225dad3053b83bc},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42367793. Agents can read the archived copy with the MCP tool read_document.